Cargando…
SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway
Structure-specific recognition protein 1 (SSRP1) has been considered as a potential biomarker, since aberrant high expression of SSRP1 has been detected in numerous malignant tumors. However, the correlation between the expression level of SSRP1 and glioma remains unclear. The present study attempte...
Autores principales: | Liao, Jianming, Tao, Xiang, Ding, Qianshan, Liu, Junhui, Yang, Xue, Yuan, Fan-En, Yang, Ji-An, Liu, Baohui, Xiang, Guo-An, Chen, Qianxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780019/ https://www.ncbi.nlm.nih.gov/pubmed/29048646 http://dx.doi.org/10.3892/or.2017.5982 |
Ejemplares similares
-
SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497
por: Ding, Qianshan, et al.
Publicado: (2016) -
SSRP1 promotes colorectal cancer progression and is negatively regulated by miR‐28‐5p
por: Wu, Wei, et al.
Publicado: (2019) -
miR-181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma
por: Tang, Dong, et al.
Publicado: (2020) -
Glioma Stem Cell-Targeted Dendritic Cells as a Tumor Vaccine Against Malignant Glioma
por: Ji, Baowei, et al.
Publicado: (2013) -
Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis
por: Xu, Pengfei, et al.
Publicado: (2018)